First Internet (NASDAQ:INBK) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1.13 by 12.39 percent. This is a 23.3 percent increase over earnings of $1.03 per share from the same period last year.
ImmunoGen’s Newly Approved Ovarian Cancer Drug Listed As Preferred Regime
The National Comprehensive Cancer Network (NCCN) released new guidelines for ovarian cancer treatment, which include ImmunoGen Inc's (NASDAQ: IMGN) Elahere (mirvetuximab soravtansine-gynx) as a preferred regimen.
